RecallRadar

FDA Drug recall D-0353-2023

Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured by Lloyd Inc., Shenandoah, IA, 51601, Distributed b…

On 2023-03-08 the FDA classified a Class II recall of Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured by Lloyd Inc., Shenandoah, IA, 51601, Distributed b… by Alvogen, citing sub-Potent Drug: Out of specification for assay at the 24 month interval.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0353-2023
ClassificationClass II
Statusterminated
Initiated2023-02-06
Published2023-03-08
Last updated2026-09-13 11:52 UTC
CompanyAlvogen
DistributionUS

Product

Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured by Lloyd Inc., Shenandoah, IA, 51601, Distributed by: Alvogen Inc, Pine Brook, NJ 07058, NDC 47781-654-90.

Reason

Sub-Potent Drug: Out of specification for assay at the 24 month interval.

Identifiers

ndc47781-640-90
ndc47781-640-10
ndc47781-643-90
ndc47781-643-10
ndc47781-646-90
ndc47781-646-10
ndc47781-649-90
ndc47781-649-10
ndc47781-651-90
ndc47781-651-10
ndc47781-654-90
ndc47781-654-10
ndc47781-657-90
ndc47781-657-10
ndc47781-659-90
ndc47781-659-10
ndc47781-662-90
ndc47781-662-10
ndc47781-665-90
ndc47781-665-10
ndc47781-668-90
ndc47781-668-10
ndc47781-671-90
ndc47781-671-10
ndc47781-728-90
ndc47781-721-90
code_infoLot # HE02221, Exp. 05/2023

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0353-2023%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.